Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | thioredoxin glutathione reductase | 0.2457 | 1 | 1 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0851 | 0 | 0.5 |
Plasmodium vivax | glutathione reductase, putative | 0.2457 | 1 | 1 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0851 | 0 | 0.5 |
Treponema pallidum | NADH oxidase | 0.0851 | 0 | 0.5 |
Trypanosoma brucei | trypanothione reductase | 0.2457 | 1 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.2457 | 1 | 1 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0851 | 0 | 0.5 |
Leishmania major | trypanothione reductase | 0.2457 | 1 | 1 |
Plasmodium falciparum | glutathione reductase | 0.2457 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0851 | 0 | 0.5 |
Loa Loa (eye worm) | thioredoxin reductase | 0.2457 | 1 | 0.5 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0851 | 0 | 0.5 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0851 | 0 | 0.5 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0851 | 0 | 0.5 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.2457 | 1 | 1 |
Toxoplasma gondii | thioredoxin reductase | 0.2457 | 1 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.2457 | 1 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.2457 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0851 | 0 | 0.5 |
Brugia malayi | Thioredoxin reductase | 0.2457 | 1 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.2457 | 1 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.2457 | 1 | 1 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0851 | 0 | 0.5 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0851 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 40 % | Inhibition of LPS-induced NO production in mouse BV2 microglia cells assessed as nitrite levels at 100 uM relative to untreated control | ChEMBL. | 17980460 |
Activity (functional) | = 52 % | Inhibition of LPS-induced tetrahydrobiopterin production in mouse BV2 microglia cells assessed as tetrahydrobiopterin levels at 100 uM relative to untreated control | ChEMBL. | 17980460 |
Activity (functional) | = 59 % | Inhibition of LPS-induced tetrahydrobiopterin production in mouse BV2 microglia cells assessed as tetrahydrobiopterin levels at 30 uM relative to untreated control | ChEMBL. | 17980460 |
Activity (functional) | = 59 % | Inhibition of LPS-induced tetrahydrobiopterin production in mouse BV2 microglia cells assessed as tetrahydrobiopterin levels at 60 uM relative to untreated control | ChEMBL. | 17980460 |
Activity (functional) | = 99 % | Inhibition of LPS-induced tetrahydrobiopterin production in mouse BV2 microglia cells assessed as tetrahydrobiopterin levels at 10 uM relative to untreated control | ChEMBL. | 17980460 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.